Webinar on Diabetes Drug Development

Xtalks presents a live webinar on October 19, 2012 at 11:00am EDT on Diabetes Drug Development: A Perspective on Pediatric Indication Planning. Our speakers, Cynthia Jackson, DO, Leader, Pediatric Center of Excellence, Quintiles, and Paul Strumph, MD, Leader, Diabetes Center of Excellence, Quintiles, will provide insight into the various regulations which direct pediatric diabetes drug development for registration globally. Register for the webinar at http://xtks.in/xto-527

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Toronto, Canada (PRWEB) October 08, 2012

The regulations governing pediatric clinical trials have undergone significant changes over the past decade. Join us to gain insight into better decision making during the overall development process for diabetes therapies.

Key points of discussion include what every diabetes drug development team should know about evolving EU and US pediatric regulations, case history, lessons learned, and planning for success. Our speakers will additionally provide their perspective for a pediatric indication plan roadmap.

For more information or to register go to http://xtks.in/xto-527

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com


Contact

  • Client Services
    Xtalks
    (416) 977-6555 227
    Email